NR0B2 and neoplasm: Regarding the mechanisms involved, in vitro studies suggest that the overexpression of NR0B2 can inhibit hepatocellular carcinoma (HCC) lesions’ formation and tumor growth, potentially through SHP’s (the protein corresponding to NR0B2) regulation of cyclin D1 [8].